Russell Alan J's Form 4/A amendment
AmendedEdgewise Therapeutics, Inc. (EWTX) · filed Aug 17, 2026
- Accession no.
- 0001853529-26-000003
- Filed
- Aug 17, 2026, 6:40 PM ET
- Trade date
- Aug 12, 2026
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Aug 14, 2026
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $258.0K. It was filed 5 days after the trade.
This amendment replaces 0001853529-26-000002 (filed Aug 14, 2026).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Russell Alan JCIK 0001853529 | Director, Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | MOption exerciseAcquired | +5,781 | $0.00 | $0 | 30,336 | Direct | |
| Aug 12, 2026 | Common Stock | MOption exerciseAcquired | +7,031 | $0.00 | $0 | 37,367 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −3,238 | $43.68 | −$141,427.75 | 34,129 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −2,273 | $43.68 | −$99,275.32 | 31,856 | Direct | |
| Aug 12, 2026 | Common Stock | SSaleDisposed | −390 | $44.46 | −$17,339.4 | 31,466 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | MOption exerciseDisposed | −5,781 | $0.00 | $0 | 11,563 | Direct | |
| Aug 12, 2026 | Common Stock | MOption exerciseDisposed | −7,031 | $0.00 | $0 | 21,094 | Direct | |
| Aug 12, 2026 | Common Stock | AGrant or awardAcquired | +32,500 | $0.00 | $0 | 32,500 | Direct | |
| Aug 12, 2026 | Common Stock | AGrant or awardAcquired | +65,000 | $0.00 | $0 | 65,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.